Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy.

Sousa, M; Peate, M; Lewis, C; Jarvis, S; Willis, A; Hickey, M; Friedlander, M

Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy.

Sousa, M Peate, M Lewis, C Jarvis, S Willis, A Hickey, M Friedlander, M

Permalink

Publisher:: WILEY
Publication Type:: Journal Article
Citation:: Eur J Cancer Care (Engl), 2018, 27, (2), pp. e12820
Issue Date:: 2018-03

Closed Access

	Filename	Description	Size
	European J Cancer Care - 2018 - Sousa - Exploring knowledge attitudes and experience of genitourinary symptoms in women.pdf	Published version	375.79 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Sousa, M
dc.contributor.author	Peate, M
dc.contributor.author	Lewis, C
dc.contributor.author	Jarvis, S
dc.contributor.author	Willis, A
dc.contributor.author	Hickey, M
dc.contributor.author	Friedlander, M
dc.date.accessioned	2022-04-19T03:53:00Z
dc.date.available	2017-12-17
dc.date.available	2022-04-19T03:53:00Z
dc.date.issued	2018-03
dc.identifier.citation	Eur J Cancer Care (Engl), 2018, 27, (2), pp. e12820
dc.identifier.issn	0961-5423
dc.identifier.issn	1365-2354
dc.identifier.uri	http://hdl.handle.net/10453/156431
dc.description.abstract	Clinical trials of adjuvant endocrine therapy in women with early breast cancer have consistently reported that genitourinary symptoms are common. However, little is known about women's experiences of genitourinary symptoms, their views about the symptoms and how they impact on their lives. The aim of this study was to explore knowledge, attitudes and experiences of genitourinary symptoms among women receiving adjuvant endocrine therapy for early breast cancer. Thirty-two semi-structured interviews were conducted and subjected to a rigorous qualitative analysis. Genitourinary symptoms were commonly reported to negatively impact on personal, social and physical activities, were often attributed to anxiety and stress and were a source of embarrassment. Women also commented on the limited information available or provided regarding the potential genitourinary adverse effects of adjuvant endocrine therapy. There was a general lack of awareness that their symptoms could be associated with or exacerbated by adjuvant endocrine therapy. Women indicated a preference to receive information and advice about potential management options from either their general practitioner or specialist. These findings underscore the importance of improving communication and increasing awareness among both clinicians and patients about the potential impact of adjuvant endocrine therapy on genitourinary symptoms.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	WILEY
dc.relation.ispartof	Eur J Cancer Care (Engl)
dc.relation.isbasedon	10.1111/ecc.12820
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1110 Nursing, 1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.mesh	Adult
dc.subject.mesh	Aged
dc.subject.mesh	Antineoplastic Agents, Hormonal
dc.subject.mesh	Anxiety
dc.subject.mesh	Attitude to Health
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	Chemotherapy, Adjuvant
dc.subject.mesh	Female
dc.subject.mesh	Female Urogenital Diseases
dc.subject.mesh	Health Knowledge, Attitudes, Practice
dc.subject.mesh	Help-Seeking Behavior
dc.subject.mesh	Humans
dc.subject.mesh	Life Change Events
dc.subject.mesh	Middle Aged
dc.subject.mesh	Patient Acceptance of Health Care
dc.subject.mesh	Self Report
dc.subject.mesh	Sexual Dysfunction, Physiological
dc.subject.mesh	Urinary Incontinence
dc.subject.mesh	Humans
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	Urinary Incontinence
dc.subject.mesh	Antineoplastic Agents, Hormonal
dc.subject.mesh	Chemotherapy, Adjuvant
dc.subject.mesh	Attitude to Health
dc.subject.mesh	Health Knowledge, Attitudes, Practice
dc.subject.mesh	Anxiety
dc.subject.mesh	Life Change Events
dc.subject.mesh	Adult
dc.subject.mesh	Aged
dc.subject.mesh	Middle Aged
dc.subject.mesh	Patient Acceptance of Health Care
dc.subject.mesh	Female
dc.subject.mesh	Sexual Dysfunction, Physiological
dc.subject.mesh	Female Urogenital Diseases
dc.subject.mesh	Self Report
dc.subject.mesh	Help-Seeking Behavior
dc.title	Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy.
dc.type	Journal Article
utslib.citation.volume	27
utslib.location.activity	England
utslib.for	1110 Nursing
utslib.for	1112 Oncology and Carcinogenesis
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2022-04-19T03:52:59Z
pubs.issue	2
pubs.publication-status	Published
pubs.volume	27
utslib.citation.issue	2

Abstract:

Clinical trials of adjuvant endocrine therapy in women with early breast cancer have consistently reported that genitourinary symptoms are common. However, little is known about women's experiences of genitourinary symptoms, their views about the symptoms and how they impact on their lives. The aim of this study was to explore knowledge, attitudes and experiences of genitourinary symptoms among women receiving adjuvant endocrine therapy for early breast cancer. Thirty-two semi-structured interviews were conducted and subjected to a rigorous qualitative analysis. Genitourinary symptoms were commonly reported to negatively impact on personal, social and physical activities, were often attributed to anxiety and stress and were a source of embarrassment. Women also commented on the limited information available or provided regarding the potential genitourinary adverse effects of adjuvant endocrine therapy. There was a general lack of awareness that their symptoms could be associated with or exacerbated by adjuvant endocrine therapy. Women indicated a preference to receive information and advice about potential management options from either their general practitioner or specialist. These findings underscore the importance of improving communication and increasing awareness among both clinicians and patients about the potential impact of adjuvant endocrine therapy on genitourinary symptoms.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/156431